Recent progress in the understanding and treatment of transthyretin amyloidosis.
What is known and objective Transthyretin ( TTR) is a representative amyloidogenic protein in humans. Rate-limiting tetramer dissociation and rapid monomer misfolding and misassembly of variant TTR result in autosomal dominant familial amyloidosis. Analogous misfolding of wild-type TTR results in se...
| Published in: | Journal of Clinical Pharmacy & Therapeutics Vol. 39; no. 3; pp. 225 - 234 |
|---|---|
| Main Author: | |
| Format: | pictorial review tables/charts Journal Article |
| Published: |
Wiley-Blackwell
Jun2014
|
| Online Access: | View this record in EBSCOhost |